First patient dosed in AskBio’s AB-1003 trial
4th August 2023 Uncategorised 0Research is evaluating the company’s novel investigational FKRP gene replacement therapy More: First patient dosed in AskBio’s AB-1003 trial Source: News
read more
Research is evaluating the company’s novel investigational FKRP gene replacement therapy More: First patient dosed in AskBio’s AB-1003 trial Source: News
read moreTherapy is a treatment option for adults with severe and moderately severe haemophilia B More: NICE rejection for CSL Behring gene therapy Source: News
read moreNovo Nordisk, Eli Lilly face injury lawsuit from user of popular GLP-1 medicines kdunleavy Thu, 08/03/2023 – 14:35 More: Novo Nordisk, Eli Lilly face injury lawsuit from user of popular GLP-1 medicines Source: fierce
read moreBavarian Nordic locks up $120M BARDA deal to replenish US stock of smallpox, mpox vaccine fkansteiner Thu, 08/03/2023 – 11:27 More: Bavarian Nordic locks up 0M BARDA deal to replenish US stock of smallpox, mpox vaccine Source: fierce
read moreAs sales crater, Moderna sees hope in private COVID vaccine market and RSV launch zbecker Thu, 08/03/2023 – 10:21 More: As sales crater, Moderna sees hope in private COVID vaccine market and RSV launch Source: fierce
read moreMerck KGaA suffers CDMO slump after ‘sharp drop’ in COVID-related sales, CFO says fkansteiner Thu, 08/03/2023 – 10:15 More: Merck KGaA suffers CDMO slump after 'sharp drop' in COVID-related sales, CFO says Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals